83bar executive Kate Hermans to speak at DPharm Conference 2019

- Ms. Hermans, chief business officer, shares views on driving patient empowerment in clinical trial recruitment
- Case study of more than 1,000 patients demonstrates why delivering personalization at scale is not only necessary, but possible
- Based on 83bar experience using its 4-step Patient Activation process in clinical trial recruitment

AUSTIN, Texas - Txylo -- Kate Hermans, chief business officer for pharma at 83bar LLC, will speak on patient empowerment at the 9th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference September 17-18, 2019 in Boston, MA.

Joining Ms. Hermans at the conference from 83bar will be Alex Hilderbrand, vice president, and Mike Zangrilli, senior technology manager.

83bar has a fully integrated digital health technology and concierge platform to individualize Patient Activation at scale. The platform's use for clinical trial recruitment shows meaningful results for study sponsors, investigator sites, and patients.

The case study Ms. Hermans will present demonstrates why delivering personalization at scale is not only necessary, but possible. Key points include:

More on Txylo.com
  • How to unlock the power of data for successful clinical trial recruitment
  • The historic velocity of change in clinical development and drug approval ecosystem
  • Intelligent trials and decentralized trials, coupled with growing number of rare and ultra-rare disease trials, are changing drug delivery model
  • Ways to integrate the recruitment platform can expand patient pool, make trials faster, less complex, and ultimately less costly
  • Innovative approaches to drive patient empowerment in clinical trial process
  • Improving the quality of patient experience and its real-world implications for development of new therapies and medical devices
The presentation is the first by 83bar at the DPharm Conference. 83bar is among more than 20 pharma companies which are reporting on specific innovations to better deliver new medicines.

About DPharm 2019

DPharm 2019 will cover the full spectrum of clinical research, including virtual trials, digital applications, real-world data, big data management, AI applications, MAPs, EHR eSource operations, patient-centric strategies, new business models, collaborations and technologies. More information at https://theconferenceforum.org/conferences/disruptive-innovations-us/overview/

More on Txylo.com
About 83bar, LLC

83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system that has been implemented by nearly three dozen name brands in health, medical, technology, and devices. The company has a database of nearly one million patient engagements over the past three years. Its four-step activation process is a system integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care. Contact at www.go83bar.com

Mark Stinson, VP Brand Management
83bar, LLC

Source: 83bar, LLC
Filed Under: Health, Marketing

Show All News | Report Violation


Latest on Txylo.com